Skip to main content Skip to section navigation Skip to footer
Becton, Dickinson and Company - Corporate Home
  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Clinical Microbiology
      • Diagnostic Accuracy and Efficiency
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
    • Pharmacy
      • BD Hypodermic Needle and Syringe Solutions
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Plastic and Reconstructive Surgery Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
    • Customer Portals
      • Medication Management Customer Login
      • Customer Care Portal Guides and FAQ’s
      • My BD Learning
  • About BD
    • Our Company
      • About BD
      • Segments
      • Leadership
      • Board of Directors
      • Ethics and Compliance
    • BD IV Fluid Support
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • Corporate Sustainability
      • Climate Change
      • Healthy Workforce & Communities
      • Product Impact
      • Supply Chain
      • Transparency
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
      • Supplier Recognition
  • Careers
  • Country

    United States

    • North America
      • Canada (EN)
      • Canada (FR)
      • Mexico
      • United States
      South America
      • América Latina
      • Argentina
      • Chile
      • Colombia
      Europe
      • Belgique
      • België
      • Česká republika
      • Deutschland
      • España
      • Europe
      • France
      • ישראל
      • Italia
      • Nederland
      • Nordics
      • Österreich
      • Polska
      • Schweiz
      • United Kingdom
      Middle East, North Africa, Turkey
      • Middle East, North Africa, Turkey
      • South Africa
      Asia Pacific
      • Australia & New Zealand
      • 中国
      • Greater Asia
      • India
      • 日本
      • 대한민국
      • Southeast Asia
  • Login Here

    Login

  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
      • BD Hypodermic Needle and Syringe Solutions
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Clinical and Lab Support
      • Clinical Microbiology
      • Diagnostic Accuracy and Efficiency
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
    • Pharmacy
      • BD Hypodermic Needle and Syringe Solutions
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Pharmaceutical Microbiology
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • BD Hypodermic Needle and Syringe Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Plastic and Reconstructive Surgery Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
    • Customer Portals
      • Medication Management Customer Login
      • Customer Care Portal Guides and FAQ’s
      • My BD Learning
  • About BD
    • Our Company
      • About BD
      • Segments
      • Leadership
      • Board of Directors
      • Ethics and Compliance
    • BD IV Fluid Support
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • Corporate Sustainability
      • Climate Change
      • Healthy Workforce & Communities
      • Product Impact
      • Supply Chain
      • Transparency
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
      • Supplier Recognition
  • Careers
  • Country

    United States

    • North America
      • Canada (EN)
      • Canada (FR)
      • Mexico
      • United States
    • South America
      • América Latina
      • Argentina
      • Chile
      • Colombia
    • Europe
      • Belgique
      • België
      • Česká republika
      • Deutschland
      • España
      • Europe
      • France
      • ישראל
      • Italia
      • Nederland
      • Nordics
      • Österreich
      • Polska
      • Schweiz
      • United Kingdom
    • Middle East, North Africa, Turkey
      • Middle East, North Africa, Turkey
      • South Africa
    • Asia Pacific
      • Australia & New Zealand
      • 中国
      • Greater Asia
      • India
      • 日本
      • 대한민국
      • Southeast Asia
  • Login here Login

Financial Results

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • BD Innovates
    • Email Alerts
    • Other Notices
  • Company Info
    • Overview
    • Executive Leadership
    • Annual Reports and Proxy
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Credit Rating
    • Additional Financial Information
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
    • Stock Split History
    • Dividends
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Sustainability
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
    • Contact the Board
    • Reporting Accounting, Internal Accounting Controls or Auditing Matters
  • Financial Info

  • Overview
  • Financial Results
  • Credit Rating
  • Additional Financial Information

2025

Q2 FY25

Quarter Ended Mar 31, 2025
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY25

Quarter Ended Dec 31, 2024
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-Q HTML PDF XBRL Zip

2024

Q4 FY24

Fiscal Year Ended Sep 30, 2024
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-K HTML PDF XBRL Zip

Q3 FY24

Quarter Ended Jun 30, 2024
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY24

Quarter Ended Mar 31, 2024
Earnings Release HTML PDF
Earnings Webcast Audio
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY24

Quarter Ended Dec 31, 2023
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2023

Q4 FY23

Fiscal Year Ended Sep 30, 2023
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY23

Quarter Ended Jun 30, 2023
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY23

Quarter Ended Mar 31, 2023
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY23

Quarter Ended Dec 31, 2022
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2022

Q4 FY22

Fiscal Year Ended Sep 30, 2022
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY22

Quarter Ended Jun 30, 2022
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY22

Quarter Ended Mar 31, 2022
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY22

Quarter Ended Dec 31, 2021
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2021

Q4 FY21

Fiscal Year Ended Sep 30, 2021
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY21

Quarter Ended Jun 30, 2021
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY21

Quarter Ended Mar 31, 2021
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY21

Quarter Ended Dec 31, 2020
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

2020

Q4 FY20

Fiscal Year Ended Sep 30, 2020
Year End Results
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY20

Quarter Ended Jun 30, 2020
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

Q2 FY20

Quarter Ended Mar 31, 2020
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

Q1 FY20

Quarter Ended Dec 31, 2019
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

2019

Q4 FY19

Fiscal Year Ended Sep 30, 2019
Year End Results
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY19

Quarter Ended Jun 30, 2019
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

Q2 FY19

Quarter Ended Mar 31, 2019
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

Q1 FY19

Quarter Ended Dec 31, 2018
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

2018

Q4 FY18

Fiscal Year Ended Sep 30, 2018
Year End Results
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY18

Quarter Ended Jun 30, 2018
Earnings Release HTML PDF
Presentation PDF
Earnings Infographic PDF
10-Q HTML PDF XBRL Zip

Q2 FY18

Quarter Ended Mar 31, 2018
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY18

Quarter Ended Dec 31, 2017
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2017

Q4 FY17

Fiscal Year Ended Sep 30, 2017
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY17

Quarter Ended Jun 30, 2017
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY17

Quarter Ended Mar 31, 2017
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY17

Quarter Ended Dec 31, 2016
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2016

Q4 FY16

Fiscal Year Ended Sep 30, 2016
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY16

Quarter Ended Jun 30, 2016
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY16

Quarter Ended Mar 31, 2016
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY16

Quarter Ended Dec 31, 2015
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2015

Q4 FY15

Fiscal Year Ended Sep 30, 2015
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY15

Quarter Ended Jun 30, 2015
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY15

Quarter Ended Mar 31, 2015
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY15

Quarter Ended Dec 31, 2014
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2014

Q4 FY14

Fiscal Year Ended Sep 30, 2014
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY14

Quarter Ended Jun 30, 2014
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY14

Quarter Ended Mar 31, 2014
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY14

Quarter Ended Dec 31, 2013
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2013

Q4 FY13

Fiscal Year Ended Sep 30, 2013
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY13

Quarter Ended Jun 30, 2013
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY13

Quarter Ended Mar 31, 2013
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY13

Quarter Ended Dec 31, 2012
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2012

Q4 FY12

Fiscal Year Ended Sep 30, 2012
Year End Results
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY12

Quarter Ended Jun 30, 2012
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY12

Quarter Ended Mar 31, 2012
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q1 FY12

Quarter Ended Dec 31, 2011
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

2011

Q4 FY11

Fiscal Year Ended Sep 30, 2011
Year End Results
Presentation PDF
10-K HTML PDF XBRL Zip
Annual Report PDF

Q3 FY11

Quarter Ended Jun 30, 2011
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF XBRL Zip

Q2 FY11

Quarter Ended Mar 31, 2011
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

Q1 FY11

Quarter Ended Dec 31, 2010
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

2010

Q4 FY10

Fiscal Year Ended Sep 30, 2010
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF
Annual Report PDF

Q3 FY10

Quarter Ended Jun 30, 2010
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

Q2 FY10

Quarter Ended Mar 31, 2010
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

Q1 FY10

Quarter Ended Dec 31, 2009
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

2009

Q4 FY09

Fiscal Year Ended Sep 30, 2009
Year End Results
Earnings Release HTML PDF
Presentation PDF
10-K HTML PDF
10-K/A HTML PDF
10-K/A HTML PDF
Annual Report PDF

Q3 FY09

Quarter Ended Jun 30, 2009
Earnings Release HTML PDF
Presentation PDF
10-Q HTML PDF

Q2 FY09

Quarter Ended Mar 31, 2009
Presentation PDF
10-Q HTML PDF

Q1 FY09

Quarter Ended Dec 31, 2008
Earnings Release HTML PDF
10-Q HTML PDF
By reading this content you are acknowledging our forward looking statement.

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company's control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.

  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • accessibilityAccessibility Statement
  • Follow us
    • Linked In
    • Facebook
    • Instagram
    • Twitter
    • Youtube
Quick Links
  • Recalls and Field Actions
  • Careers
  • Cybersecurity
  • Electronic Instructions for Use
  • Events
  • Investors
  • Inclusion, Diversity, Equity & Engagement
  • Literature
  • Live Chat Support
  • News, Media and Blogs
  • Our Company
  • Ethics and Compliance
  • Support
  • Training
Becton, Dickinson and Company

©2025 BD. All rights reserved. BD and the BD Logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners.

  • Contact us
  • Cookie Preferences
  • Privacy Statement
  • Terms of Use
  • Website Accessibility
  • Your Privacy Rights
  • Limit the use of Sensitive Personal Information